Asthma is a chronic lung disease characterized by hyper responsiveness of tracheobronchial smooth muscle to stimuli, resulting in narrowing and inflammation of air tubes, accompanied by increased secretion, swelling and build-up of tissue fluid. Symptoms include tight chest, wheezing, cough and may be limitation of activity due to difficulty in breathing.

Market Analysis and Insights: Global Anti Asthma Drugs Market
The global Anti Asthma Drugs market was valued at US$ 22250 in 2020 and will reach US$ 27190 million by the end of 2027, growing at a CAGR of 3.4% during 2022-2027.

Global Anti Asthma Drugs Scope and Market Size
The global Anti Asthma Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti Asthma Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Bronchodilators
Leukotriene Antagonists
Mast Cell Stabilizers
Corticosteroids
Monoclonal Antibody

Segment by Application
Clinics
Hospitals
Other

The Anti Asthma Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Anti Asthma Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
GlaxoSmithKline
Merck & Co
AstraZeneca
F. Hoffmann-La Roche
Teva Pharmaceutical
Novartis International
Boehringer Ingelheim
Sunovion Pharmaceuticals